Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Home
Biocon Limited
Press Release Feb 06 2025
Business
Feb 6 2025
5 min read

Press Release Feb 06 2025

Biocon Limited has informed the Exchange regarding a press release dated February 06, 2025, titled "Equillium Inc. and Biocon Limited Announce Positive Data from Phase 2 Study Evaluating Itolizumab in Patients with Moderate to Severe Ulcerative Colitis".

View Attachment